Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 922 results for "gsk"

GlaxoSmithKline: An Undervalued 'Work In Progress'
Seeking Alpha

GlaxoSmithKline: An Undervalued 'Work In Progress'

Jul. 5, 2015 2:53 AM ET | About: GlaxoSmithKline (GSK) by: Summary GSK is in the middle of turnaround. Return on equity looks impressive initially, but why? High yield, but no dividend growth. My plans going forward. GlaxoSmithKline ... Seeking Alpha, 1 hour ago
[x]  

667 images for gsk

Bio Spectrum Asia, 1 day ago
InvestorPoint.com, 1 hour ago
Bio Spectrum Asia, 2 days ago
Reuters India, 3 days ago
This is Money, 2 days ago
The New Age Online, 2 days ago
Business Insider, 3 days ago
ChannelAfrica.co.za, 3 days ago
IChainnel, 2 days ago
EventFAQs, 5 days ago
Bio Spectrum Asia

GSK to Produce Price-cutting Anti-AIDs Drugs in China

GSK has signed an agreement of producing price-cutting anti-AIDS drugs in China, showing the company is rebuilding its influence in China following a corruption scandal. According to an agreement reached by GSK's AIDS drug department ViiV Healthcare ...
 Individual.com1 day ago GSK tries to repair image in China with HIV drug tie-up  Yahoo! UK and Ireland2 days ago GSK inks deal with China drugmaker for HIV drugs  Bio Spectrum Asia2 days ago Relations between GlaxoSmithKline and China thawing as drug maker announces deal to make HIV medicine with Shanghai firm Desano Pharmaceuticals  This is Money2 days ago
[x]  

Director/PDMR Shareholding

Regulatory Story GlaxoSmithKline PLC - GSK Released 15:34 01-Jul-2015 RNS Number : 9025R GlaxoSmithKline PLC 01 July 2015 GlaxoSmithKline plc Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected ...
 London Stock Exchange3 days ago Total Voting Rights  London Stock Exchange3 days ago
Financial Express

Research and Markets Adds Report: Global Cancer Vaccines Market 2015-2019 With Dendreon, GSK & Merck Dominating

Research and Markets has announced the addition of the "Global Cancer Vaccines Market 2015-2019" report to its offerings. In a release, Research and Markets noted that report highlights include: The global cancer vaccines market to grow at a ...
 Individual.com2 days ago Global Cancer Vaccines Market 2015-2019 with Dendreon, GSK & Merck Dominating  Individual.com4 days ago Research and Markets: Global Cancer Vaccines Market 2015-2019 With Dendreon, GSK & Merck Dominating  Benzinga.com4 days ago RESEARCH AND MARKETS : Global Cancer Vaccines Market 2015-2019 With Dendreon, GSK & Merck Dominating  4 Traders4 days ago
[x]  
Tech Times

ViiV Healthcare inks manufacturing deal for production of dolutegravir in China

ViiV Healthcare , the joint venture between GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE), secures a manufacturing agreement with Shanghai-based Desano Pharmaceuticals for the production of dolutegravir in China. The deal provides an additional ...
 Seeking Alpha2 days ago ViiV Healthcare and China's Desano sign manufacturing deal for new HIV drug Tivicay  Pharmaceutical Technology2 days ago GSK And Desano Manufacturing Deal Could Mean Cheaper HIV Drugs For China  Tech Times2 days ago

Potential GlaxoSmithKline PLC (GSK) Trade Targets 2.61% Return

GlaxoSmithKline Plc (http://www.marketintelligencecenter.com/symbol/GSK"GSK) traded between $42.00 and $42.77 before closing at $42.03 Monday and presents some attractive trading opportunities today according to MarketIntelligenceCenter.com's ...
 Individual.com4 days ago GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Resistance At $43.52  Individual.com5 days ago
Bio Spectrum Asia

GSK to invest $60mn in its green manufacturing facility

Singapore: British drug giant GlaxoSmithKline announced plans to invest an additional $60 mn in its world-class antibiotic manufacturing plant at Quality Road in Singapore, building on its initial investment of $35 mn committed in 2012. According ...
 Bio Spectrum Asia2 days ago
Seeking Alpha

PSA: Afrezza Is NOT Exubera

Jul. 2, 2015 8:12 PM ET | About: MannKind Corporation (MNKD), Includes: GSK, PFE, SNY by: Danny Katz Summary Many websites have begun publishing bearish articles on MannKind Corporation. Most of the articles have flawed reasoning and are ...
 Seeking Alpha2 days ago

GSK holds doctor webinars

A new initiative using web seminars or 'webinars' to disseminate information to medical professionals on the latest developments in the treatment, management or prevention of diseases has been launched in Sri Lanka by GlaxoSmithKline (GSK) ...
 Sri Lanka Daily News2 days ago

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Jul. 2, 2015 9:08 AM ET | About: Gilead Sciences, Inc. (GILD), Includes: GSK, MRK, MYL, TEVA by: Kanak Kanti De Summary Gilead files third NDA for its TAF product, battling ViiV's Triumeq. Pristiq generics from Mylan and others get ...
 Seeking Alpha2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gsk
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less